Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma.

Abi-Jaoudeh, Nadine; Dayyani, Farshid; Chen, Pei Jer; Fernando, Dayantha; Fidelman, Nicholas; Javan, Hanna; Liang, Po-Chin; Hwang, Jen-I; Imagawa, David K

Abi-Jaoudeh, Nadine; Dayyani, Farshid; Chen, Pei Jer; Fernando, Dayantha; Fidelman, Nicholas; Javan, Hanna; Liang, Po-Chin; Hwang, Jen-I; Imagawa, David K.

Afiliación

Abi-Jaoudeh N; Department of Radiological Sciences, University of California Irvine, Orange, CA, USA.
Dayyani F; Chao Comprehensive Digestive Disease, University of California Irvine, Orange, CA, USA.
Chen PJ; Hepatitis Research Center, National Taiwan University, Taipei City, Taiwan.
Fernando D; Department of Radiological Sciences, University of California Irvine, Orange, CA, USA.
Fidelman N; Department of Radiology, University of California San Francisco, San Francisco, CA, USA.
Javan H; Department of Radiological Sciences, University of California Irvine, Orange, CA, USA.
Liang PC; Department of Medical Imaging, National Taiwan University, Taipei City, Taiwan.
Hwang JI; Department of Radiology, Taichung Veteran General Hospital, Taichung, Taiwan.
Imagawa DK; Surgery Services, University of California Irvine, Orange, CA, USA.

J Hepatocell Carcinoma ; 8: 421-434, 2021.

Article en En | MEDLINE | ID: mdl-34041204

Palabras clave

hepatocellular carcinoma; hypoxia activated agent; image guided locoregional therapies; phase I trial; transarterial chemoembolization

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Hepatocell Carcinoma Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google